BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32543905)

  • 1. Advances in the discovery of exosome inhibitors in cancer.
    Zhang H; Lu J; Liu J; Zhang G; Lu A
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1322-1330. PubMed ID: 32543905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer.
    Kim JH; Lee CH; Baek MC
    Exp Mol Med; 2022 Nov; 54(11):1833-1843. PubMed ID: 36446847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
    Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
    Front Immunol; 2021; 12():692654. PubMed ID: 34149737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function and therapeutic development of exosomes for cancer therapy.
    Kim SB
    Arch Pharm Res; 2022 May; 45(5):295-308. PubMed ID: 35604532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome mediated communication within the tumor microenvironment.
    Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
    J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying exosome release in cancer therapy: How can it help?
    Moloudizargari M; Asghari MH; Abdollahi M
    Pharmacol Res; 2018 Aug; 134():246-256. PubMed ID: 29990623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective pharmacological inhibition alters human carcinoma lung cell-derived extracellular vesicle formation.
    Ipinmoroti AO; Pandit R; Crenshaw BJ; Sims B; Matthews QL
    Heliyon; 2023 Jun; 9(6):e16655. PubMed ID: 37303541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy.
    Mukherjee A; Bisht B; Dutta S; Paul MK
    Acta Pharmacol Sin; 2022 Nov; 43(11):2759-2776. PubMed ID: 35379933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Small Vimentin-Binding Molecule Blocks Cancer Exosome Release and Reduces Cancer Cell Mobility.
    Wu J; Xie Q; Liu Y; Gao Y; Qu Z; Mo L; Xu Y; Chen R; Shi L
    Front Pharmacol; 2021; 12():627394. PubMed ID: 34305581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications.
    Ren X; Kang C; Garcia-Contreras L; Kim D
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.
    Kar R; Dhar R; Mukherjee S; Nag S; Gorai S; Mukerjee N; Mukherjee D; Vatsa R; Chandrakanth Jadhav M; Ghosh A; Devi A; Krishnan A; Thorat ND
    ACS Biomater Sci Eng; 2023 Feb; 9(2):577-594. PubMed ID: 36621949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer.
    Datta A; Kim H; McGee L; Johnson AE; Talwar S; Marugan J; Southall N; Hu X; Lal M; Mondal D; Ferrer M; Abdel-Mageed AB
    Sci Rep; 2018 May; 8(1):8161. PubMed ID: 29802284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions.
    Guo BB; Bellingham SA; Hill AF
    J Biol Chem; 2016 Mar; 291(10):5128-37. PubMed ID: 26769968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy.
    Liu H; Deng S; Han L; Ren Y; Gu J; He L; Liu T; Yuan ZX
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 1):112163. PubMed ID: 34736220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation.
    Abdullah M; Takase H; Nunome M; Enomoto H; Ito J; Gong JS; Michikawa M
    J Alzheimers Dis; 2016 Jul; 53(4):1433-41. PubMed ID: 27392863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of exosome release by extracellular DNA is conserved across multiple cell types.
    Iliev D; Strandskog G; Nepal A; Aspar A; Olsen R; Jørgensen J; Wolfson D; Ahluwalia BS; Handzhiyski J; Mironova R
    FEBS J; 2018 Aug; 285(16):3114-3133. PubMed ID: 29953723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome and Secretion: Action On?
    Hu Y; Zhang R; Chen G
    Adv Exp Med Biol; 2020; 1248():455-483. PubMed ID: 32185722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.